2. Signaling Pathways
  3. Anti-infection
  4. HIV
  5. HIV-2 Isoform
  6. HIV-2 Inhibitor

HIV-2 Inhibitor

HIV-2 Inhibitors (33):

Cat. No. Product Name Effect Purity
  • HY-10046
    Plerixafor
    		Inhibitor ≥98.0%
    Plerixafor (AMD 3100) is a selective CXCR4 antagonist with an IC50 of 44 nM.
  • HY-50912
    Plerixafor octahydrochloride
    		Inhibitor ≥98.0%
    Plerixafor octahydrochloride (AMD3100 octahydrochloride) is a selective CXCR4 antagonist with an IC50 of 44 nM.
  • HY-17427
    Emtricitabine
    		Inhibitor 99.94%
    Emtricitabine is an inhibitor of the nucleoside reverse transcriptase (NRTI) and human immunodeficiency virus type 1 (HIV-1); inhibits NRTI with an EC50 of 0.01 µM in PBMC cell.
  • HY-14882
    Cenicriviroc
    		Inhibitor 99.01%
    Cenicriviroc (TAK-652) is an orally active, dual CCR2/CCR5 antagonist, also inhibits both HIV-1 and HIV-2, and displays potent anti-inflammatory and antiinfective activity.
  • HY-15232
    Tenofovir alafenamide
    		Inhibitor 99.92%
    Tenofovir alafenamide (GS-7340) is an investigational oral prodrug of Tenofovir.
  • HY-P2200
    Siamycin I
    		Inhibitor
    Siamycin I (BMY-29304), a 21-residue tricyclic peptide, is a secondary metabolite in actinomycetes.
  • HY-P4292
    H-Gly-Pro-Gly-NH2
    		Inhibitor
    H-Gly-Pro-Gly-NH2 is a tripeptide that inhibits HIV-1 replication.
  • HY-N10776
    Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside
    		Inhibitor
    Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside is a glucopyranoside.
  • HY-15457
    Triciribine
    		Inhibitor 99.81%
    Triciribine is a DNA synthesis inhibitor, also inhibits Akt and HIV-1/2 with IC50 of 130 nM, and 0.02-0.46 μM, respectively.
  • HY-90005
    Etravirine
    		Inhibitor 99.56%
    Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.
  • HY-B0116
    Stavudine
    		Inhibitor 99.67%
    Stavudine (d4T) is an orally active nucleoside reverse transcriptase inhibitor (NRTI).
  • HY-14882A
    Cenicriviroc Mesylate
    		Inhibitor 99.04%
    Cenicriviroc Mesylate (TAK-652 Mesylate) is a dual CCR2/CCR5 antagonist, also inhibits both HIV-1 and HIV-2, and displays potent anti-inflammatory and antiinfective activity.
  • HY-15232A
    Tenofovir alafenamide fumarate
    		Inhibitor 99.91%
    Tenofovir alafenamide fumarate (GS-7340 fumarate) is an investigational oral prodrug of Tenofovir.
  • HY-W013441
    2',3'-Dideoxyadenosine
    		Inhibitor 99.89%
    2',3'-Dideoxyadenosine is an inhibitor of HIV replication.
  • HY-19314A
    Azvudine hydrochloride
    		Inhibitor
    Azvudine (RO-0622) hydrochloride is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV.
  • HY-P1066
    Apelin-17(human, bovine)
    		Inhibitor
    Apelin-17(human, bovine) is an endogenous orphan G protein-coupled receptor APJ agonist.
  • HY-15232B
    Tenofovir alafenamide hemifumarate
    		Inhibitor 99.70%
    Tenofovir alafenamide hemifumarate (GS-7340 hemifumarate) is an investigational oral prodrug of Tenofovir.
  • HY-14134
    BMS-378806
    		Inhibitor 98.89%
    BMS-378806 is a potent HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.
  • HY-17003
    Saquinavir mesylate
    		Inhibitor 99.89%
    Saquinavir mesylate is an HIV Protease Inhibitor used in antiretroviral therapy.
  • HY-16776
    Censavudine
    		Inhibitor 98.18%
    Censavudine (OBP-601; BMS-986001), a nucleoside analog, is a nucleoside reverse transcriptase inhibitor.